首页> 外国专利> HYBRID CELL LINE FOR PRODUCING MONOCLONAL ANTIBODY TO A HUMAN PROTHYMOCYTE ANTIGEN,ANTIBODY,METHOD OF PREPARATION OF THIS ANTIBODY,DIAGNOSTIC AND THERAPEUTIC USES,AND PHARMACEUTICAL COMPOSITIONS COMPRISING THIS ANTIBODY

HYBRID CELL LINE FOR PRODUCING MONOCLONAL ANTIBODY TO A HUMAN PROTHYMOCYTE ANTIGEN,ANTIBODY,METHOD OF PREPARATION OF THIS ANTIBODY,DIAGNOSTIC AND THERAPEUTIC USES,AND PHARMACEUTICAL COMPOSITIONS COMPRISING THIS ANTIBODY

机译:用于生产人类原核细胞抗原,单克隆抗体,该抗体的制备方法,诊断和治疗用途以及包含该抗体的药物成分的混合细胞系

摘要

Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 95% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
机译:用于在大约95%的正常人胸腺细胞上产生针对抗原的单克隆抗体的杂交细胞系。该杂种是通过将来自免疫CAF1小鼠的脾细胞与P3X63Ag8U1骨髓瘤细胞融合而形成的。还公开了单克隆抗体的诊断和治疗用途。

著录项

  • 公开/公告号IE50725B1

    专利类型

  • 公开/公告日1986-06-25

    原文格式PDF

  • 申请/专利权人 ORTHO PHARMACEUTICAL CORPORATION;

    申请/专利号IE19800002511

  • 发明设计人

    申请日1980-12-03

  • 分类号C12N5/00;C12N15/00;G01N33/577;A61K39/395;

  • 国家 IE

  • 入库时间 2022-08-22 07:41:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号